Ignite Creation Date:
2025-12-24 @ 7:49 PM
Ignite Modification Date:
2026-03-03 @ 6:44 PM
Study NCT ID:
NCT02974504
Status:
COMPLETED
Last Update Posted:
2018-07-23
First Post:
2016-11-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase IV Clinical Trial to Investigate the Effect on Blood Glucose of Evogliptin in Patients With Type 2 Diabetes(EVERGREEN)
Sponsor:
Dong-A ST Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-09
Start Date Type:
None
Primary Completion Date:
2018-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-03
Completion Date Type:
ACTUAL
First Submit Date:
2016-11-23
First Submit QC Date:
None
Study First Post Date:
2016-11-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-07-19
Last Update Post Date:
2018-07-23
Last Update Post Date Type:
ACTUAL